Abrocitinib for pediatric Toxicodendron contact dermatitis

Liyang Duan, Xianjie Wu · 2026

Read Abrocitinib for pediatric Toxicodendron contact dermatitis by Liyang Duan, Xianjie Wu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13527479.txt.

Description

Liyang Duan and Xianjie Wu describe, in a 2026 case report, treating a child's severe contact dermatitis from lacquer tree exposure with abrocitinib, a targeted immune drug. Allergic contact dermatitis is a delayed T-cell reaction, and standard care relies on avoidance, topical steroids, calamine, and antihistamines, which can fall short in children with widespread disease.

An eight-year-old boy developed intensely itchy red papules and plaques over trunk and limbs for ten days after exposure to Toxicodendron vernicifluum. Three days of topical steroid, emollients, and an antihistamine failed as the rash spread to his face, with a severity score in the severe range. His parents declined systemic steroids over growth concerns, so after counseling the team started daily oral abrocitinib plus nightly cetirizine. Photographs chart facial clearing by day three and near resolution by day eleven.

Catalog record

CREATORLiyang Duan, Xianjie Wu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE7309
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13527479

Browse the full library · About the Tower of Babel